ACIU
Price
$2.53
Change
+$0.05 (+2.02%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
249.49M
59 days until earnings call
ADVM
Price
$2.98
Change
-$0.09 (-2.93%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
64.42M
Interact to see
Advertisement

ACIU vs ADVM

Header iconACIU vs ADVM Comparison
Open Charts ACIU vs ADVMBanner chart's image
AC Immune SA
Price$2.53
Change+$0.05 (+2.02%)
Volume$8.39K
Capitalization249.49M
Adverum Biotechnologies
Price$2.98
Change-$0.09 (-2.93%)
Volume$200
Capitalization64.42M
ACIU vs ADVM Comparison Chart in %
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. ADVM commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Buy and ADVM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (ACIU: $2.54 vs. ADVM: $3.02)
Brand notoriety: ACIU and ADVM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 86% vs. ADVM: 30%
Market capitalization -- ACIU: $249.49M vs. ADVM: $64.42M
ACIU [@Biotechnology] is valued at $249.49M. ADVM’s [@Biotechnology] market capitalization is $64.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileADVM’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • ADVM’s FA Score: 0 green, 5 red.
According to our system of comparison, ACIU is a better buy in the long-term than ADVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 5 TA indicator(s) are bullish while ADVM’s TA Score has 5 bullish TA indicator(s).

  • ACIU’s TA Score: 5 bullish, 4 bearish.
  • ADVM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ACIU is a better buy in the short-term than ADVM.

Price Growth

ACIU (@Biotechnology) experienced а +15.45% price change this week, while ADVM (@Biotechnology) price change was -12.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was +6.95%, and the average quarterly price growth was +36.10%.

Reported Earning Dates

ACIU is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACIU($249M) has a higher market cap than ADVM($64.4M). ACIU YTD gains are higher at: -8.148 vs. ADVM (-34.261). ACIU has higher annual earnings (EBITDA): -48.05M vs. ADVM (-172.21M). ACIU has more cash in the bank: 127M vs. ADVM (44.4M). ACIU has less debt than ADVM: ACIU (4.92M) vs ADVM (92.2M). ACIU has higher revenues than ADVM: ACIU (28.9M) vs ADVM (1M).
ACIUADVMACIU / ADVM
Capitalization249M64.4M387%
EBITDA-48.05M-172.21M28%
Gain YTD-8.148-34.26124%
P/E RatioN/AN/A-
Revenue28.9M1M2,890%
Total Cash127M44.4M286%
Total Debt4.92M92.2M5%
FUNDAMENTALS RATINGS
ACIU vs ADVM: Fundamental Ratings
ACIU
ADVM
OUTLOOK RATING
1..100
8286
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4960
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADVM's Valuation (35) in the Biotechnology industry is in the same range as ACIU (48) in the Pharmaceuticals Major industry. This means that ADVM’s stock grew similarly to ACIU’s over the last 12 months.

ADVM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ACIU (100) in the Pharmaceuticals Major industry. This means that ADVM’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as ADVM (100) in the Biotechnology industry. This means that ACIU’s stock grew similarly to ADVM’s over the last 12 months.

ACIU's Price Growth Rating (49) in the Pharmaceuticals Major industry is in the same range as ADVM (60) in the Biotechnology industry. This means that ACIU’s stock grew similarly to ADVM’s over the last 12 months.

ACIU's P/E Growth Rating (84) in the Pharmaceuticals Major industry is in the same range as ADVM (100) in the Biotechnology industry. This means that ACIU’s stock grew similarly to ADVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUADVM
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 19 days ago
87%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JPXGY10.680.05
+0.47%
Japan Exchange Group, Inc.
ACSYF0.87N/A
N/A
Accsys Technologies Plc.
CNAF8.00N/A
N/A
Commercial National Financial Corp. (PA)
MAWHF0.60N/A
N/A
Man Wah Holdings, Ltd.
MSSUF10.05N/A
N/A
Metal Sky Star Acquisition Corporation

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with RGNX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
+2.06%
RGNX - ACIU
39%
Loosely correlated
-1.20%
IMVT - ACIU
37%
Loosely correlated
-3.90%
IRON - ACIU
37%
Loosely correlated
+0.13%
ADVM - ACIU
37%
Loosely correlated
+1.66%
ARCT - ACIU
36%
Loosely correlated
+4.68%
More

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with XENE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
+1.66%
XENE - ADVM
49%
Loosely correlated
-0.61%
RGNX - ADVM
48%
Loosely correlated
-1.20%
OCUL - ADVM
47%
Loosely correlated
-2.11%
NRIX - ADVM
46%
Loosely correlated
-4.09%
IMNM - ADVM
46%
Loosely correlated
+2.93%
More